Plasma samples from n=8 stage IV osimertinib-treated EGFR p.T790M-positive patients with lung adenocarcinoma were longitudinally collected and analyzed using capture-based targeted DNA and methylated DNA sequencing. Here, EGFR is linked to lung adenocarcinoma.